BMY:NYE-Bristol-Myers Squibb Company (USD)

EQUITY | Drug Manufacturers - General | New York Stock Exchange

Last Closing

USD 53.25

Change

+0.70 (+1.33)%

Market Cap

USD 93.95B

Volume

0.01B

Analyst Target

USD 73.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
LLY Eli Lilly and Company

+8.64 (+1.19%)

USD 745.60B
JNJ Johnson & Johnson

-0.68 (-0.46%)

USD 367.23B
MRK Merck & Company Inc

+0.48 (+0.37%)

USD 318.60B
ABBV AbbVie Inc

-7.67 (-4.58%)

USD 297.12B
NVS Novartis AG ADR

-1.62 (-1.64%)

USD 195.80B
PFE Pfizer Inc

+0.14 (+0.55%)

USD 150.96B
GSK GlaxoSmithKline PLC ADR

+0.20 (+0.49%)

USD 85.52B
OGN Organon & Co

+0.13 (+0.71%)

USD 4.56B

ETFs Containing BMY

MEDX Horizon Kinetics Medical .. 5.43 % 0.00 %

-0.02 (0.07%)

USD 0.75B
FHI-B:CA CI Health Care Giants Cov.. 5.10 % 0.00 %

N/A

CAD 0.05B
LIFE-B:CA Evolve Global Healthcare .. 5.03 % 0.00 %

N/A

CAD 0.01B
XGES:LSE Xtrackers MSCI Genomic He.. 4.63 % 0.00 %

+0.39 (+0.07%)

USD 3.51M
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.22 % 0.00 %

+0.38 (+0.07%)

USD 0.15B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.21 % 0.00 %

+0.49 (+0.07%)

USD 3.51M
XDGI:XETRA Xtrackers MSCI Global SDG.. 3.51 % 0.00 %

+0.45 (+0.07%)

USD 0.01B
RUD-U:CA RBC Quant U.S. Dividend L.. 3.28 % 0.00 %

+0.49 (+0.07%)

N/A
DHS:SW WisdomTree US Equity Inco.. 2.95 % 0.00 %

N/A

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.95 % 0.00 %

N/A

USD 0.04B
TDIV:SW VanEck Morningstar Develo.. 2.78 % 0.00 %

-0.22 (0.07%)

USD 0.64B
TDGB:LSE VanEck Morningstar Develo.. 2.70 % 0.00 %

+0.08 (+0.07%)

USD 0.58B
TDIV:LSE VanEck Morningstar Develo.. 2.70 % 0.00 %

+0.13 (+0.07%)

USD 0.64B
HEAL:CA 2.66 % 0.00 %

N/A

N/A
FHH:CA First Trust AlphaDEX US H.. 1.99 % 0.77 %

N/A

CAD 0.01B
FHH-F:CA First Trust AlphaDEX U.S... 1.99 % 0.00 %

N/A

CAD 0.01B
H41D:XETRA HSBC MSCI World Value ESG.. 1.91 % 0.00 %

+0.34 (+0.07%)

USD 0.18B
FTLS First Trust Long/Short Eq.. 1.85 % 1.59 %

+0.45 (+0.07%)

USD 1.13B
PUD.B:CA 1.82 % 0.66 %

N/A

N/A
UVDV 1.72 % 0.00 %

N/A

N/A
JAVA JPMorgan Active Value ETF 1.53 % 0.00 %

+0.06 (+0.07%)

USD 1.04B
UC82:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

+1.75 (+0.07%)

USD 0.07B
UC86:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

+0.02 (+0.07%)

USD 0.30B
SPXB ProShares S&P 500® Bond .. 1.32 % 0.15 %

N/A

USD 9.35M
FELV Fidelity Enhanced Large C.. 0.98 % 0.00 %

+0.02 (+0.07%)

USD 1.93B
UC98:LSE UBS(Lux)Fund Solutions .. 0.74 % 0.00 %

+9.00 (+0.07%)

USD 0.18B
BSUS:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

+4.25 (+0.07%)

USD 0.16M
UC97:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

+0.07 (+0.07%)

USD 0.18B
UET0:F UBS (Lux) Fund Solutions .. 0.65 % 0.00 %

+0.07 (+0.07%)

N/A
UET0:XETRA UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

+0.06 (+0.07%)

USD 0.21B
CBSUST:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

+0.06 (+0.07%)

USD 0.03B
CBSUS:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

+0.10 (+0.07%)

USD 0.18B
CBSUSE:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

+0.04 (+0.07%)

USD 0.24B
CBSUSH:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

USD 0.06B
QUIG:CA Mackenzie US Investment G.. 0.62 % 0.28 %

N/A

CAD 0.48B
UC76:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

+0.06 (+0.07%)

USD 0.08B
UC85:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

+6.50 (+0.07%)

USD 0.06B
DEW WisdomTree Global High Di.. 0.00 % 0.58 %

-0.06 (0.07%)

USD 0.11B
DHS WisdomTree U.S. High Divi.. 0.00 % 0.38 %

-0.48 (0.07%)

USD 1.08B
GBF iShares Government/Credit.. 0.00 % 0.20 %

+0.22 (+0.07%)

USD 0.24B
IHE iShares U.S. Pharmaceutic.. 0.00 % 0.42 %

+0.58 (+0.07%)

USD 0.69B
JHMH 0.00 % 0.46 %

N/A

N/A
QLTA iShares Aaa - A Rated Cor.. 0.00 % 0.15 %

+0.10 (+0.07%)

USD 1.02B
NUBD Nuveen ESG U.S. Aggregate.. 0.00 % 0.20 %

+0.04 (+0.07%)

USD 0.34B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

+0.06 (+0.07%)

USD 0.02B
HONR 0.00 % 0.65 %

N/A

N/A
DSTL Distillate US Fundamental.. 0.00 % 0.00 %

+0.16 (+0.07%)

USD 1.74B
HUL-U:CA 0.00 % 0.00 %

N/A

N/A
RUD:CA RBC Quant US Dividend Lea.. 0.00 % 0.43 %

+0.38 (+0.07%)

CAD 0.48B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

N/A

USD 1.09M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

N/A

USD 1.09M
SICK 0.00 % 0.95 %

N/A

N/A
UXM.B:CA 0.00 % 0.67 %

N/A

N/A
HUL:CA 0.00 % 2.20 %

N/A

N/A
BVAL 0.00 % 0.65 %

N/A

N/A
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+6.40 (+0.07%)

USD 0.03B
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.01 (+0.07%)

USD 0.04B
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.01 (+0.07%)

USD 0.03B
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.25 (+0.07%)

USD 0.75M
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+7.75 (+0.07%)

USD 0.04B
LUMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

+55.00 (+0.07%)

USD 0.01B
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

+8.50 (+0.07%)

USD 0.08B
USMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

-0.30 (0.07%)

USD 0.01B
XSD2:LSE db x-trackers ShortDAX x2.. 0.00 % 0.00 %

-2.29 (0.07%)

USD 0.13B
MVUS:PA Ossiam US Minimum Varianc.. 0.00 % 0.00 %

N/A

USD 0.01B
SPMV:PA Ossiam US Minimum Varianc.. 0.00 % 0.00 %

N/A

USD 7.79M
OSX2:F Ossiam Lux - Ossiam US Mi.. 0.00 % 0.00 %

-0.05 (0.07%)

N/A
VDIV:F VanEck Vectors ETFs N.V... 0.00 % 0.00 %

-0.06 (0.07%)

USD 0.64B
WTD9:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.02 (+0.07%)

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

+0.07 (+0.07%)

USD 0.64M
WTEU:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

USD 0.11B
OSX2:XETRA Ossiam US Minimum Varianc.. 0.00 % 0.00 %

+0.80 (+0.07%)

USD 0.12B
VDIV:XETRA VanEck Morningstar Develo.. 0.00 % 0.00 %

+0.27 (+0.07%)

USD 0.64B
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
WTD9:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

+0.10 (+0.07%)

USD 0.05B
WTDY:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

+0.01 (+0.07%)

USD 0.85M
WTEU:XETRA WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.09 (+0.07%)

USD 0.11B
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
HART IQ Healthy Hearts ETF 0.00 % 0.00 %

+0.20 (+0.07%)

USD 8.64M

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.78% 44% F 53% F
Dividend Return 1.17% 67% D+ 60% D-
Total Return 4.95% 44% F 54% F
Trailing 12 Months  
Capital Gain -21.90% 22% F 11% F
Dividend Return 3.39% 44% F 49% F
Total Return -18.51% 22% F 11% F
Trailing 5 Years  
Capital Gain 11.61% 50% F 53% F
Dividend Return 21.02% 75% C 74% C
Total Return 32.63% 63% D 54% F
Average Annual (5 Year Horizon)  
Capital Gain 4.28% 67% D+ 58% F
Dividend Return 7.50% 67% D+ 60% D-
Total Return 3.22% 56% F 64% D
Risk Return Profile  
Volatility (Standard Deviation) 18.80% 33% F 59% D-
Risk Adjusted Return 39.91% 44% F 67% D+
Market Capitalization 93.95B 33% F 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers - General) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 13.80 89% 61%
Price/Book Ratio 3.61 78% 24%
Price / Cash Flow Ratio 7.77 89% 46%
Price/Free Cash Flow Ratio 6.99 100% 56%
Management Effectiveness  
Return on Equity 26.53% 63% 89%
Return on Invested Capital 24.13% 78% 90%
Return on Assets 5.63% 33% 76%
Debt to Equity Ratio 124.54% 38% 27%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.